Tactical Therapeutics, Inc. (Tactical)

Oncology Corporate Profile

HQ Location

44 Wall Street, Suite 2003
New York, NY 10005

Company Description

Tactical Therapeutics Inc (“TTI”) is a clinical stage company that has developed and patented a lead therapeutic Carboxyamidotriazole Orate (CTO) for the orphan indication glioblastoma.

Website: http://www.tacticaltherapeutics.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
CTO (+ ccnu)multiple oncokinase inhibitorGliomaII
CTO (+ temodar)multiple oncokinase inhibitorGliomaII
CTO (+ avastin)multiple oncokinase inhibitorGliomaII
CTOmultiple oncokinase inhibitorGliomaII

View additional information on product candidates here »

Pipeline image

Recent News Headlines

There are no news items to display